Schroder Investment Management Group Incyte Corp Transaction History

Schroder Investment Management Group

$94.4 Billion
Q1 2025

A detailed history of Schroder Investment Management Group transactions in Incyte Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 16,753 shares of INCY stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,753

Previous 195,393 91.43%

Holding current value

$1.15 Million

Previous $13.5 Million 92.49%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$60.0 - $75.26 $10.7 Million - $13.4 Million	-178,640 Reduced 91.43%	16,753 $1.01 Million
Q4 2024 Feb 12, 2025	BUY	$65.08 - $83.38 $11.9 Million - $15.2 Million	182,836 Added 1456.05%	195,393 $13.5 Million
Q3 2024 Nov 13, 2024	SELL	$57.33 - $68.61 $2.38 Million - $2.85 Million	-41,570 Reduced 76.8%	12,557 $830,000
Q2 2024 Aug 12, 2024	SELL	$51.18 - $63.75 $9.24 Million - $11.5 Million	-180,447 Reduced 76.93%	54,127 $3.28 Million
Q1 2024 May 14, 2024	SELL	$56.55 - $66.59 $7.53 Million - $8.86 Million	-133,113 Reduced 36.2%	234,574 $13.4 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $18.7 Million - $23 Million	358,272 Added 3805.33%	367,687 $23.1 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $751 - $857	13 Added 0.14%	9,415 $543,000
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $155,849 - $193,079	2,557 Added 37.36%	9,402 $585,000
Q1 2023 May 11, 2023	SELL	$70.23 - $86.01 $63,768 - $78,097	-908 Reduced 11.71%	6,845 $494,000
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $25,528 - $31,961	380 Added 5.15%	7,753 $622,000
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $16,412 - $20,549	248 Added 3.48%	7,373 $492,000
Q2 2022 Aug 11, 2022	SELL	$66.18 - $83.18 $52,083 - $65,462	-787 Reduced 9.95%	7,125 $540,000
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $194,230 - $234,506	-2,942 Reduced 27.11%	7,912 $631,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $1.02 Million - $1.19 Million	-16,064 Reduced 59.68%	10,854 $797,000
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $12.9 Million - $15.8 Million	-187,877 Reduced 87.47%	26,918 $1.85 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $13 Million - $14.2 Million	162,235 Added 308.67%	214,795 $18.1 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $3.58 Million - $4.73 Million	47,045 Added 853.04%	52,560 $4.27 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $1.16 Million - $1.5 Million	-13,680 Reduced 71.27%	5,515 $490,000
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $1.17 Million - $1.71 Million	15,739 Added 455.41%	19,195 $2 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $758,160 - $1.03 Million	-12,000 Reduced 77.64%	3,456 $294,000
Q4 2017 Feb 09, 2018	BUY	$93.56 - $116.6 $1.45 Million - $1.8 Million	15,456	15,456 $1.46 Million

Others Institutions Holding INCY

# of Institutions

697

Shares Held

194M

Call Options Held

564K

Put Options Held

331K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Incyte Corp Transaction History